Riskpilot← Back to searchSign inGet full accessCOLOSSEUM MEDISPA AS
ASActiveOrg 980019268Middelthunsgate 21, 0368 OsloDay spa, sauna and steam bath activities · NACE 9623Est. 199812 employeeswww.colosseum-spa.no
Revenue 2024
NOK 10,7M
-1% vs 2023
EBITDA margin
1.6%
+162% vs 2023
Equity ratio
-18.1%
Financial strength
Net profit 2024
NOK -130K
+62% vs 2023
| Revenue | NOK 10,7M | -1% |
| EBITDA | NOK 169K | +162% |
| Net profit | NOK -130K | +62% |
| Total assets | NOK 5,7M | -2% |
| Equity | NOK -1M | -14% |
| Employees | 12 | — |
Legal name
COLOSSEUM MEDISPA AS
Org number
980019268
Legal form
Aksjeselskap
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
25. juni 1998
Share capital
NOK 694 300
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder eller nestleder hver for seg.
Company purpose
Levere tjenester innen helse, hud og kroppspleie, samt deltagelse i andre selskaper innen slik virksomhet. Selskapet leier lokaler til virksomheten.
Address
Middelthunsgate 21, 0368 Oslo
Phone
+4723215400
Email
post@colosseum-spa.no
Website
www.colosseum-spa.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 814 | 10 990 | 11 727 | 10 858 | 10 743 |
| Staff expenses | −4 644 | −5 928 | −6 111 | −5 119 | −4 922 |
| EBITDA | 198 | −432 | −705 | −272 | 169 |
| Depreciation & amort. | −346 | −190 | −206 | −162 | −316 |
| EBIT | −148 | −623 | −911 | −434 | −147 |
| Net financials | −26 | −2 | 2 | −6 | −20 |
| Profit before tax | −174 | −625 | −909 | −440 | −167 |
| Tax | −38 | −137 | −199 | −97 | −37 |
| Net profit | −136 | −487 | −710 | −343 | −130 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 782 | 4 308 | 4 088 | 5 837 | 5 705 |
| Equity | −477 | −215 | −560 | −903 | −1 033 |
| Long-term debt | 573 | 0 | 183 | 2 016 | 3 116 |
| Short-term debt | 3 686 | 4 523 | 4 465 | 4 724 | 3 622 |
| Total debt | 4 260 | 4 523 | 4 648 | 6 740 | 6 738 |
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
20202024
Equity ratio
-18.1%
This company
38.2%
Market median
-147% vs market
20202024
Return on equity
-12998700.0%
This company
18.4%
Market median
-70645209% vs market
20202024
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20202024
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20202024
Debt / equity
6.52×
This company
0.62×
Market median
-952% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NB Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 96.76% | 96.76% | 2024 | |
| Individual | 3.24% | 3.24% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scandinavian Beauty As
COLOSSEUM MEDISPA AS Board members of COLOSSEUM MEDISPA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nabila Bougroug | Chief Executive Officer | 0 companies |
| Geir Håvard Kvalheim | Chairman | 0 companies |
| Tom Eddy Ødegård | Board of Directors | 0 companies |
| Nina Rollum | Board of Directors | 0 companies |